Drugs / GSK3277513A
last change Mar 2017 re-read 3 minutes ago

GSK3277513A

Developed for
respiratory system disorder
Investigated by
GlaxoSmithKline

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02547974 Aug 2015 → Mar 2017 respiratory system disorder GlaxoSmithKline Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GSK3277513A ClinicalTrials.gov intervention name — accepted as the source's own label NCT02547974 ↗
Route Intramuscular “Intramuscular vaccination in the deltoid region of the non-dominant arm according to protocol schedule” NCT02547974 ↗